Stockscreener 앱 받기
3.71
0.00%
0.00
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Is Nuvation Bio Inc. Warrants stock undervalued after correctionMarket Movement Recap & Step-by-Step Trade Execution Guides - newser.com
Can Nuvation Bio Inc. Class stock resist broad market declinesMarket Activity Report & Safe Entry Momentum Tips - newser.com
Is Nuvation Bio Inc. stock resilient to inflationWeekly Stock Report & Fast Gaining Stock Reports - newser.com
Will Nuvation Bio Inc. Class stock top growth indexesBond Market & Capital Efficient Trading Techniques - newser.com
Is Nuvation Bio Inc. reversing from oversold territoryJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
Will Nuvation Bio Inc. Warrants stock sustain uptrend momentumMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
Custom watchlist performance reports with Nuvation Bio Inc.Earnings Growth Summary & Stepwise Swing Trade Plans - newser.com
How big funds are accumulating Nuvation Bio Inc. Warrants stockGlobal Markets & Technical Buy Zone Confirmations - newser.com
Nuvation Bio Inc. stock retracement – recovery analysis2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
How Nuvation Bio Inc. Class stock moves in volatile trading sessionsOptions Play & Real-Time Volume Trigger Notifications - newser.com
Will Nuvation Bio Inc. stock continue dividend increasesMarket Growth Review & Low Drawdown Investment Ideas - newser.com
How moving averages guide Nuvation Bio Inc. tradingMarket Growth Summary & Free Fast Gain Swing Trade Alerts - newser.com
Assessing Nuvation Bio (NUVB) Valuation After Recent Share Price Momentum in the Biotech Sector - Yahoo
Nuvation Bio Hits Day High with 15.63% Surge in Strong Intraday Performance - Markets Mojo
Multi factor analysis applied to Nuvation Bio Inc.Market Movers & Accurate Intraday Trade Tips - newser.com
Nuvation Bio (NUVB)’s Taletrectinib Selected as Preferred Agent for Cancer Treatment - MSN
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer - Investing News Network
Jefferies initiates Nuvation Bio stock with Buy rating, $10 price target - Investing.com Nigeria
Why Nuvation Bio Stock Is Skyrocketing Today - Mitrade
Nuvation Bio Shares Rise After First Patient Enrolled in Phase 3 Lung Cancer Drug Trial - MarketScreener
Nuvation issues trial update as Jefferies says buy (NUVB) - Seeking Alpha
United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday - Benzinga
Jefferies Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq
Nuvation Bio enrolls first patient in phase 3 lung cancer trial - Investing.com
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer - Business Wire
What market sentiment indicators show for Nuvation Bio Inc. Class stockProduct Launch & Low Risk Investment Opportunities - newser.com
3 Of My Favorite Biotech Stocks Under $10 - Seeking Alpha
Will breakout in Nuvation Bio Inc. lead to full recoveryMarket Weekly Review & Verified Entry Point Signals - newser.com
Why Nuvation Bio Inc. stock is popular among millennials2025 Valuation Update & High Accuracy Trade Alerts - newser.com
Nuvation Bio Surges on Japanese Approval of Ibtrozi for Lung Cancer - StocksToTrade
Nuvation Bio (NUVB) Surges Amid Major Regulatory Milestone in Japan - timothysykes.com
What analysts say about Nuvation Bio Inc stockMorning Star Patterns & Discover Strategies with Fellow Traders - earlytimes.in
Nuvation Bio Soars As Japan Approves Ibtrozi for Advanced Lung Cancer - StocksToTrade
Nuvation Bio Stock Hits Day Low of $3.00 Amid Price Pressure - Markets Mojo
Nuvation Bio (NYSE:NUVB) Stock Price Up 7.2%Here's Why - MarketBeat
2.68%
0.38%
자본화:
|
볼륨(24시간):